BioAdaptives, Inc. (BDPT)

USD 0.06

(0.0%)

Market Cap (In USD)

73.9 Million

Revenue (In USD)

28.56 Thousand

Net Income (In USD)

-712.46 Thousand

Avg. Volume

7.48 Million

Currency
USD
Country
Consumer Defensive
Open
-
Prev. Close
-
Day Range
-
Year Range
2.0E-4-0.42
PE
-
EPS
-
Beta Value
0.346
ISIN
US09072U1079
CUSIP
09072U107
CIK
1575142
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Consumer Defensive
Industry
Packaged Foods
CEO
Mr. James Keener
Employee Count
-
Website
https://www.shopbioadaptives.com
Ipo Date
2014-07-09
Details
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. The company focuses on offering health and wellness products, such as dietary supplements. It offers PrimiCell, PluriPain, PrimiLungs, PrimiLive, and PrimiSleep, as well as markets Lung Flute for humans; Canine Regen and Equine Regen for dogs and horses, as well as base formulations, including Equine All-in-One to trainers, horse owners and boarding stables; and All-in-One products, which combine minerals, vitamins, amino acids, and other botanicals with the Regen compounds. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.